Catalyst Funds Management’s Parabilis Medicines PBLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$694K Buy
+21,493
New +$750K 0.08% 262

Other funds holding PBLS

Catalyst Funds Management's PBLS Position: Q3 2026 in Review

Catalyst Funds Management opened a new position in Parabilis Medicines (PBLS) in Q3 2026: 21,493 shares worth $694K. The stake represents 0.08% of the portfolio and ranks #262 among its holdings.

127 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

  • Catalyst Funds Management held 21,493 shares of Parabilis Medicines worth $694K as of Q3 2026.
  • Parabilis Medicines was a new Catalyst Funds Management position in Q3 2026.
  • Parabilis Medicines made up 0.08% of Catalyst Funds Management's portfolio in Q3 2026, its #262 holding.
  • 127 funds tracked by Wall St. Rank held Parabilis Medicines as of Q3 2026.

Based on Catalyst Funds Management's 13F filing for Q3 2026, filed 12 Nov 2026.